摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(methylseleno)<2.2>paracyclophane | 135562-20-8

中文名称
——
中文别名
——
英文名称
4-(methylseleno)<2.2>paracyclophane
英文别名
5-Methylselanyltricyclo[8.2.2.24,7]hexadeca-1(13),4,6,10(14),11,15-hexaene
4-(methylseleno)<2.2>paracyclophane化学式
CAS
135562-20-8
化学式
C17H18Se
mdl
——
分子量
301.29
InChiKey
ZZHOTSNPVJJNOZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.95
  • 重原子数:
    18
  • 可旋转键数:
    1
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

反应信息

  • 作为反应物:
    描述:
    4-(methylseleno)<2.2>paracyclophane间氯过氧苯甲酸 作用下, 以 二氯甲烷 为溶剂, 反应 0.83h, 生成 4-(methaneseleninyl)<2.2>paracyclophane
    参考文献:
    名称:
    Asymmetric induction in the oxidation of [2.2]paracyclophane-substituted selenides. Application of chirality transfer in the selenoxide [2,3] sigmatropic rearrangement
    摘要:
    When selenides derived from [2.2]paracyclophane systems were oxidized, the chiral aryl substituent provided for asymmetric induction to the new selenoxide chiral center. The ratio of diastereomeric selenoxides obtained depended upon whether the oxidation was performed under kinetic conditions or whether the selenoxides were allowed to equilibrate. Thus 4-(methylseleno)[2.2]paracyclophane (10) gave a 1:1 kinetic ratio of selenoxides 11 and 12 on oxidation with m-chloroperbenzoic acid and a 30:1 ratio at equilibrium (thermodynamic ratio). The more hindered 4-(methylseleno)-15-(p-toluenesulfonyl)[2.2]paracyclophane (23) was prepared in almost optically pure form. It gave a better kinetic ratio of selenoxides 24 and 25 (4.5:1) but a poorer thermodynamic one (1.5:1). The relative configuration of 11 and 12 and the absolute configuration of 24 and 25 were assigned. A geranyl selenide substituted with a resolved [2.2]paracyclophane substituent was oxidized and allowed to undergo a selenoxide [2,3] sigmatropic rearrangement to linalool. This sequence proves that the [2,3] sigmatropic rearrangement of gamma,gamma-dialkylallyl selenoxides proceeds through an endo transition state and illustrates the use of asymmetric induction during oxidation followed by chirality transfer by rearrangement to prepare optically active allylic alcohols.
    DOI:
    10.1021/jo00019a039
  • 作为产物:
    描述:
    4-溴[2.2]对环芳烷 在 sodium tetrahydroborate 作用下, 反应 2.33h, 生成 4-(methylseleno)<2.2>paracyclophane
    参考文献:
    名称:
    Asymmetric induction in the oxidation of [2.2]paracyclophane-substituted selenides. Application of chirality transfer in the selenoxide [2,3] sigmatropic rearrangement
    摘要:
    When selenides derived from [2.2]paracyclophane systems were oxidized, the chiral aryl substituent provided for asymmetric induction to the new selenoxide chiral center. The ratio of diastereomeric selenoxides obtained depended upon whether the oxidation was performed under kinetic conditions or whether the selenoxides were allowed to equilibrate. Thus 4-(methylseleno)[2.2]paracyclophane (10) gave a 1:1 kinetic ratio of selenoxides 11 and 12 on oxidation with m-chloroperbenzoic acid and a 30:1 ratio at equilibrium (thermodynamic ratio). The more hindered 4-(methylseleno)-15-(p-toluenesulfonyl)[2.2]paracyclophane (23) was prepared in almost optically pure form. It gave a better kinetic ratio of selenoxides 24 and 25 (4.5:1) but a poorer thermodynamic one (1.5:1). The relative configuration of 11 and 12 and the absolute configuration of 24 and 25 were assigned. A geranyl selenide substituted with a resolved [2.2]paracyclophane substituent was oxidized and allowed to undergo a selenoxide [2,3] sigmatropic rearrangement to linalool. This sequence proves that the [2,3] sigmatropic rearrangement of gamma,gamma-dialkylallyl selenoxides proceeds through an endo transition state and illustrates the use of asymmetric induction during oxidation followed by chirality transfer by rearrangement to prepare optically active allylic alcohols.
    DOI:
    10.1021/jo00019a039
点击查看最新优质反应信息

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-盐酸沙丁胺醇 (S)-溴烯醇内酯 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-3,3''-双([[1,1''-联苯]-4-基)-[1,1''-联萘]-2,2''-二醇 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-2,2'',3,3''-四氢-6,6''-二-9-菲基-1,1''-螺双[1H-茚]-7,7''-二醇 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (6,6)-苯基-C61己酸甲酯 (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,5R)-3,3a,8,8a-四氢茚并[1,2-d]-1,2,3-氧杂噻唑-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aS,8aR)-2-(吡啶-2-基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑 (3aS,3''aS,8aR,8''aR)-2,2''-环戊二烯双[3a,8a-二氢-8H-茚并[1,2-d]恶唑] (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (3S,3aR)-2-(3-氯-4-氰基苯基)-3-环戊基-3,3a,4,5-四氢-2H-苯并[g]吲唑-7-羧酸 (3R,3’’R,4S,4’’S,11bS,11’’bS)-(+)-4,4’’-二叔丁基-4,4’’,5,5’’-四氢-3,3’’-联-3H-二萘酚[2,1-c:1’’,2’’-e]膦(S)-BINAPINE (3-三苯基甲氨基甲基)吡啶 (3-[(E)-1-氰基-2-乙氧基-2-hydroxyethenyl]-1-氧代-1H-茚-2-甲酰胺) (2′′-甲基氨基-1,1′′-联苯-2-基)甲烷磺酰基铝(II)二聚体 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,4S)-Fmoc-4-三氟甲基吡咯烷-2-羧酸 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环